baber/WOPTO huggingface dataset:
Patent JP-H0833391-B2 (JP)
IPC: G01N35/00
Filed: 1989-12-21
Abstract: The method is a method of photometric in vitro determination of a blood gas parameter in a blood sample. The blood gas parameter is oxygen. The method comprises transferring the blood sample to a sample container with a transparent wall portion and with an inlet opening and otherwise being essentially sealed, said sample container incorporating a luminophor whose luminescence is quenched in the presence of oxygen, disposing the sample container in optical communication with an optical system comprising a radiation source and a radiation detector, transmitting radiation from the radiation source to the sample container to excite the luminophor, transmitting the luminescence emitted by the excited luminophor to the radiation detector, and detecting and registering the luminescence. A sample container and a system for photometric in vitro determination of oxygen in a blood sample is also described. <MATH>
Patent JP-4906169-B2 (JP)
IPC: H01L21/205
Filed: 1998-05-27
Granted: 2012-03-28
Abstract: The method concerns production of workpieces with coatings of a sufficient epitaxy quality, and is characterised by the fact that coating takes place by PECVD (plasma enhanced chemical vapour deposition) process with use of DC discharge. The claimed installation for implementation of the method includes a vacuum chamber (1), a cathode chamber (5) with at least one hot anode (7), a workpiece carrier (13) in the vacuum chamber, and an anode . The workpiece carrier is electrically insulated from the vacuum chamber.
Patent JP-3303097-B2 (JP)
IPC: A61J1/10
Filed: 1993-07-14
Granted: 2002-07-15
Abstract: An aseptic/sterile fluid connection between two containers is formed by radio frequency sealing together portions of transfer regions of two containers. Each transfer region has a layer of a relatively high melt temperature material such as a rubber or elastomer positioned between two outer container walls made of a flexible thermoplastic, for example polyvinyl chloride. The transfer regions are placed in registry, and the radio frequency welding fuses together portions of adjacent container outer walls and forms a fluid opening therethrough.
Patent JP-3929483-B2 (JP)
IPC: C07D513/04
Filed: 1994-07-15
Granted: 2007-06-13
Abstract: A trycylic benzodiazepine derivative which acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPIIbIIIa receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.
Patent JP-2841203-B2 (JP)
IPC: B05B1/34
Filed: 1988-07-05
Granted: 1998-12-24
Abstract: PCT No. PCT/EP88/00598 Sec. 371 Date Jan. 5, 1990 Sec. 102(e) Date Jan. 5, 1990 PCT Filed Jul. 5, 1988 PCT Pub. No. WO89/00086 PCT Pub. Date Jan. 12, 1989.In a manually operable discharging apparatus, the discharge nozzle has an at least two-stage atomizer, in which the medium flow, following pre-atomization, is atomized by surge-like acceleration with a whirled, fine compressed air flow, e.g. according to the Laval, effect, so that even finer droplets are obtained. For this purpose to the discharge nozzle, a separate compressed air channel portion upstream of the end opening supplies compressed air from a time immediately before the supply of medium to a time after its supply. The compressed air can be produced in simple manner by a compressed air pump combined constructionally with the medium pump and operable together therewith by means of a single handle and which in the extension of medium pump is provided immediately adjacent to its outer end and whose pump cylinder is formed by the cap-like handle. The compressed air flow can also be passed to other points of the discharging apparatus, e.g. for cleaning the medium outlet channel for discharge nozzle and can be used for control functions for valves, particularly outlet valves.
Patent JP-3095752-B2 (JP)
IPC: A61K47/48
Filed: 1988-06-07
Granted: 2000-10-10
Abstract: The present invention relates to second generation monoclonal antibodies having binding specificity to a tumor associated glycoprotein having an approximate molecular weight of >106d ("TAG-72") and human carcinomas and methods for employing the same. Hybridomas producing such antibodies have been prepared.
Patent JP-2709113-B2 (JP)
IPC: C07K14/47
Filed: 1988-08-26
Granted: 1998-02-04
Abstract: Two follistatin proteins with inhibin-like activity were isolated from porcine follicular fluid using heparin-Sepharose affinity chromatography, followed by gel filtration on Sephacryl S-200 and then six steps of high-performance liquid chromatography. Each isolated molecule is a monomer having a molecular weight of at least about 32,000 daltons. Microsequencing revealed the NH2-terminal portions both to be Gly-Asn-Cys-Trp-Leu-Arg-Gln-Ala-Lys-Asn-Gly-Arg-Cys-Gln-Val-Leu. The larger protein has 315 residues and is believed to be glycosylated. The smaller protein is a 288-residue, C-terminally shortened version thereof. These proteins specifically inhibit basal secretion of FSH, but not of LH, in a rat anterior pituitary monolayer culture system. The Half-maximal effective dose for both is 2.5-6.0 ng/ml. Human and rat follistatins exhibit very high homology with the porcine protein, with the human differing from porcine in only 4 residues out of 315 and with the rat differing from porcine in only 8 residues out of 315.
Patent JP-3302017-B2 (JP)
IPC: A61P21/00
Filed: 1992-10-22
Granted: 2002-07-15
Abstract: The invention is transfected cells, substantially all of which contain at least one human collagen gene and express fibrillar collagen molecules derived using methods for synthesizing collagen and collagen fibrils in said cell lines, and methods for treatment of disorders in humans using said collagen derived from said stable cell lines. <IMAGE>
Patent JP-2599781-B2 (JP)
IPC: A47G25/44
Filed: 1988-10-21
Granted: 1997-04-16
Abstract: PCT No. PCT/GB88/00919 Sec. 371 Date Apr. 17, 1990 Sec. 102(e) Date Apr. 17, 1990 PCT Filed Oct. 21, 1988 PCT Pub. No. WO89/03652 PCT Pub. Date May 5, 1989.The garment hanger is disclosed having a body and a hook mounted on the body to suspend the hanger on a rail. A movable arm is conveniently slidably mounted in the body for free movement in at least one direction, preferably the outward direction. A locking device is mounted on the body to lock the movable arm relative to the body against movement in an inwardly direction preferably by the interengagement of teeth on the locking device with ratchet teeth along the top edge of the corresponding movable arm. The locking means is releasable by a lever mechanism operated remotely from the locking device to allow free movement of the arm in either an outward or inward direction. Conveniently, the releasable lever mechanism is mounted on a garment engagable portion at the outermost end of the movable arm. In one preferred embodiment of a garment hanger two arms are slidably simultaneously in the hanger body in mutually opposite directions, and the locking means is mounted for engagement with one of the movable arms.
Patent JP-2989009-B2 (JP)
IPC: A61B17/34
Filed: 1992-05-05
Granted: 1999-12-13
Abstract: PCT No. PCT/SE92/00288 Sec. 371 Date Oct. 18, 1993 Sec. 102(e) Date Oct. 18, 1993 PCT Filed May 5, 1992 PCT Pub. No. WO92/19164 PCT Pub. Date Nov. 12, 1992.A device for obtaining blood comprising a rod (1) with a lancet (5), a sleeve (2), a stop (9, 15) which temporarily prevents insertion of the rod into the sleeve in a starting position in which the lancet is located in the sleeve, and two spring tongues (16, 17) which abut against the rod so that the lancet is centred and retracted into the sleeve with the aid of the spring force in the tongues. According to the invention the tongues are defined by axial slits (23) in the wall of the sleeve, whereby the tongues extend obliquely into the sleeve with their ends (19) located inside the front end (14) or an orifice ring of the sleeve. The distance between the ends of the tongues when the rod assumes said starting position, is less than the thickness of the rod at the lancet end, and the tongues are arranged to cooperate with the lancet end upon movement of the lancet.
Patent JP-3047468-B2 (JP)
IPC: C07B59/00
Filed: 1991-06-17
Granted: 2000-05-29
Abstract: Method using tetra-aryl porphyrins for and, in particular, 5,10,15,20-tetrakis(4-carboxyphenyl)porphine as a fluorescent tracer for cancers of the lung, and as a radiotracer therefor as a complex with 67Cu. The latter complex also provides a source of beta radiation for selective destruction of lung malignancies as well as gamma radiation useful for image analysis of the situs thereof by single photon emission computed tomography, as an example, both in vivo. Copper-64 may be substituted for the 67Cu if only radiotracer characteristics are of interest. This lighter isotope of copper is a positron emitter, and positron emission tomography techniques can be used to locate the malignant tissue mass.
Patent JP-2894515-B2 (JP)
IPC: E05B19/00
Filed: 1992-08-31
Granted: 1999-05-24
Abstract: A secure entry system makes use of radio transmissions to communicate with locks, keys, and related components throughout the system. The radio transmissions can be made using a paging system, a cellular telephone system, or any other RF carrier. Some embodiments employ a cellular telephone in lieu of an electronic key. Others integrate a paging receiver within an electronic key to provide a unit with dual functionality. The system is illustrated with reference to exemplary applications in the industrial site security, real estate lockbox, and transportation fields.
Patent JP-4384263-B2 (JP)
IPC: A23L27/30
Filed: 1997-08-09
Granted: 2009-12-16
Abstract: The present invention relates to a compressed formulation containing 1,1-GPS (1-O-alpha-D-glucopyranosyl-D-sorbitol) or a mixture of sweetening agents composed of 1,1-GPS, 6-0-alpha-D-glucopyranosyl-D-sorbitol (1,6-GPS) and 1-0-alpha-D-glucopyranosyl-D-mannitol (1,1 GPM).
Patent JP-3857723-B2 (JP)
IPC: C08F10/00
Filed: 1996-04-09
Granted: 2006-12-13
Abstract: The invention relates to a method for the preparation of a catalyst suitable for the polymerisation of an olefine by contacting a magnesium compound with a halogenized Ti compound, characterised in that the magnesium compound is obtained by: a) contacting metallic magnesium with an aromatic halide RX, where R is an aromatic group containing from 6 to 20 carbon atoms and X is a halide, whereupon the dissolved reaction product I is separated from the solid residual products and then b) adding an alkoxy group or aryloxy group-containing silane compound to the obtained reaction product I at a temperature of from -20 to 20  DEG C, whereupon the precipitate formed is purified to obtain reaction product II, which subsequently during a step c is contacted with TiCl4 as halogenized Ti compound and is purified to obtain a catalyst.
Patent ES-2527255-B2 (ES)
Title: Compuestos fluorescentes
Inventor: MASCARENAS CID JOSÉ LUIS
IPC: G01N23/223
Filed: 2013-06-20
Granted: 2015-06-09
Abstract: Compuestos fluorescentes. La presente invención se dirige a los compuestos de formula I, a un kit que comprende dichos compuestos y a su aplicación como agentes de tinción. Dichos compuestos están diseñados para que sean capaces de internalizarse en la célula viva, acumularse selectivamente en las mitocondrias y teñirlas de forma preferente a otros orgánulos celulares. Además tienen una elevada fotoestabilidad. Adicionalmente, los compuestos de la invención permiten ser aplicados en cultivos celulares, tanto cultivos primarios como líneas celulares, bien en células vivas o bien fijadas con parafornaldehido, manteniendo la eficacia de la tinción y su selectividad, permitiendo su uso en experimentos de visualización en tiempo real.
Patent AU-2001256034-B2 (AU)
Title: Oxygen diffuser for patient oxygen delivery system
Inventor: MCDONALD LEE
IPC: A61M16/06
Filed: 2001-05-07
Granted: 2005-06-09
Abstract: An oxygen diffuser for a lightweight oxygen delivery system for a patient, the oxygen delivery system being of the type comprising a mount for seated engagement on a patient's head or ear, an elongated tubular boom for oxygen delivery secured at one end to the mount and having the diffuser secured to the other end, the diffuser to deliver oxygen passed through the boom to a space in the vicinity of the patient's nose and mouth, the diffuser comprising a body having a wall, the interior surface of which wall is of generally concave configuration, circumscribing a centrally positioned oxygen outlet so as to direct the flow of oxygen from the outlet generally towards the patient's nose and mouth; and a baffle seated over the oxygen outlet so as to assist in mixing of oxygen with ambient air and avoid a direct flow of oxygen towards the patient's face.
Patent AU-2001260110-B2 (AU)
Title: Novel LHRH-antagonists, production and use thereof as medicament
Inventor: BERND MICHAEL
IPC: C07K1/02
Filed: 2001-03-12
Granted: 2005-05-05
Abstract: The invention relates to peptides, comprising an N-methylated amino acid component and an improved water solubility. According to the invention, medicaments containing the said peptides can be used for treatment of hormone-dependant tumours and hormone-influenced non-malignant disease states.
Patent AU-2001287160-B2 (AU)
Title: Treatment of Hepatitis C with Thymosin and Pegylated interferon
Inventor: RUDOLPH ALFRED R
IPC: A61K38/21
Filed: 2001-08-06
Granted: 2005-08-18
Abstract: A method and pharmaceutical combination for treating hepatitis C by administering to a hepatitis C patient an effective amount of at least one thymosin or an effective amount of at least thymosin fragment, in combination with administration to the hepatitis C patient of an effective amount of at least one pegylated interferon.
Patent AU-2001295773-B2 (AU)
Title: An emanator device
Inventor: JONES STUART MICHAEL RUAN
IPC: A61L9/12
Filed: 2001-10-19
Granted: 2007-03-01
Abstract: An emanator for emanating a composition into its surroundings, the emanator comprising: a container for containing a volatile liquid comprising a composition to be emanated; an emanation surface from which the volatile liquid evaporates; a wick for transporting the volatile liquid from the container to the emanation surface, characterized in that the transport of the liquid through both the wick and the emanator occurs at the surface of both the wick and the emanator and in that transport of the liquid through the wick occurs only at the surface of the wick by capillary action. In a preferred embodiment the wick and the emanation system are integrally formed from a material formed with microgrooves.
Patent AU-2001297904-B2 (AU)
Title: Plate locator for precision liquid handler
Inventor: FAWCETT KEVIN R
IPC: G01N35/00
Filed: 2001-12-31
Granted: 2005-08-11
Abstract: A locator bed has nests where sample well containing plates are held and positioned for accessing by probes moved by an X-Y-Z positioning system. Each nest includes stop posts at two sides of a rectangular base of a plate, and biasing posts at the opposed two sides. The stop posts and the biasing posts have tapered upper guide portions for guiding a descending plate into position and cylindrical lower portions receiving the base of the plate in a seated position. The stop posts are located on the surface of the locator bed by conical seat portions. The biasing posts are placed over studs fastened to the bed surface, and hoop springs are captured between the studs and the biasing posts.
Patent AU-2002321653-B2 (AU)
Title: Antenna system
Inventor: THOMAS LOUIS DAVID
IPC: H01Q1/24
Filed: 2002-09-12
Granted: 2006-09-28
Abstract: An antenna system comprises an antenna assembly (102) having antenna elements (E1-E8) mounted upon an antenna carrier and arranged in at least two sub-arrays (100A, 100B). Each sub-array (100A, 100B) includes one or more antenna elements (E1-E8). The system (100) also includes control means (104) arranged to control electrically the phase of signals supplied to at least one of the sub-arrays (100A, 100B) from a location remote from the antenna assembly (102). The control means (104) adjusts the phases of signals supplied to respective sub-arrays (100A, 100B). A mechanical phase adjustment arrangement (150E1-150E8) is provided for further adjusting the phase of signals supplied to each antenna element (E1-E8).
Patent AU-2002350449-B2 (AU)
Title: Drug delivery technology
Inventor: POTTER CHARLES DAVID OGILVY
IPC: A61M31/00
Filed: 2002-09-10
Granted: 2009-08-06
Abstract: The invention relates to a novel drug delivery technology. More particularly the invention relates to a pioneer projectile that facilitates injection of at least one therapeutic compound. The invention further relates to injectates comprising such pioneer projectiles and at least one therapeutic compound and also to disposable components comprising pioneer projectiles and/or injectates.
Patent AU-2002363658-B2 (AU)
Title: Solubilized topoisomerase poisons
Inventor: LAVOIE EDMOND J
IPC: A61K31/5025
Filed: 2002-11-14
Granted: 2008-09-11
Abstract: The invention provides compounds of formula (I) wherein A, B, W, Y, Z and R 1  have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I, and therapeutic methods for treating cancer using compounds of formula I.
Patent AU-2003213124-B2 (AU)
Title: Repellent fluorochemical compositions
Inventor: OTTESON DALE A
IPC: D06M15/27
Filed: 2003-02-18
Granted: 2009-01-08
Abstract: This invention provides compositions for treating fibrous substrates to render those substrates durably repellent to water and oil and durably resistant to dry soil comprising a 1) fluorochemical urethane formed by reacting a tri- or higher order isocyanate with a fluorochemical monofunctional compound and optionally a non-fluorinated aliphatic monofunctional compound; and 2) a fluorochemical polymeric surfactant. The present invention also provides a method of treating fibrous substrates to render those substrates durably repellent to water and oil and durably resistant to dry soil comprising application of the aforementioned composition to a fibrous substrate with optionally one or more stainblocker compounds such as acrylic and methacrylic acid polymers and copolymers, sulfonated phenol-formaldehyde resins, and styrene-maleic anhydride polymers and copolymers, said application of the composition taking place either coincident with or following application of the hydrophilic anti-staining compound or compounds to the substrate. Fibrous substrates treated according to this method and fibrous substrates treated with the aforementioned compositions are also disclosed.
Patent AU-2003220716-B2 (AU)
Title: Abrasion resistant vascular graft
Inventor: KERSHNER JAMES R
IPC: A61F2/84
Filed: 2003-07-21
Granted: 2008-11-06
Abstract: A stent-graft fabricated from a thin-walled, high strength material comprises one or more stent segments covered with a fabric formed by the weaving, knitting or braiding of a biocompatible, high tensile strength, abrasion resistant, highly durable yarn such as ultra high molecular weight polyethylene. The one or more stent segments may be balloon expandable or self-expanding. The fabric may be attached to the stent segments utilizing any number of known materials and techniques. <IMAGE>
Patent AU-2003227288-B2 (AU)
Title: Front wheel suspension system for two-wheeled vehicles
Inventor: WIMMER MARTIN F
IPC: F16F3/00
Filed: 2003-07-29
Granted: 2010-07-08
Abstract: A suspension system for the front wheel of wheeled vehicles having a single front wheel (26), such as bicycles, tricycles and motorcycles. The suspension system consists of a frame (50) with a variable arrangement of the steering points (51,53) using at least one swingable arm (52), multiple fork joints (54,55) at least one of which is designed as a two-part fork joint that provides for variable distances between the steering axis, and a telescopic fork (59) connected to the front wheel (26) and which has at least three parts so that the front wheel (26) is guided through the entire system whether partly or fully sprung.
Patent AU-2003232951-B2 (AU)
Title: Chimaeric human papillomavirus 16 L1 proteins comprising an L2 peptide, virus-like particles prepared therefrom and a method for preparing the particles.
Inventor: VARSANI ARVIND DEVSHI
IPC: C07K14/025
Filed: 2003-05-19
Granted: 2009-07-23
Abstract: A method for producing a chimaeric human papillomavirus (HPV) L1 polypeptide containing a heterologous peptide, and in particular, a HPV L2 peptide comprising the steps of introducing a DNA sequence coding for the heterologous peptide into a DNA sequence coding for the L1 polypeptide; introducing the DNA sequence including the sequences for the L1 polypeptide and heterologous peptide into a host cell in which the DNA sequence can be expressed; causing expression of the DNA sequence; and recovering the resulting chimaeric L1 polypeptide which includes the heterologous peptide. The invention also describes a vector for use in the method, a host cell containing the vector, and a vaccine including the chimaeric HPV L1 polypeptide produced according to the method.
Patent AU-2003233737-B2 (AU)
Title: Method and system for managing message-based applications and applications providers in a communications network
Inventor: COOPER ADAM
IPC: H04L12/18
Filed: 2003-06-06
Granted: 2009-06-04
Abstract: A system for a network operator to manage a message-based application, provided to a subscriber, and an application provider, providing said application, in a communications network connected to a message gateway for relaying and translating messages between the application and the subscriber. The system comprising: a subscription management module for managing publication of the application and subscription to the application by the subscriber; an application management module for managing the availability of the application based on authorization by the network operator and the application provider; and a message handler module for managing relaying, translating and enhancing, with value-added information, of the messages via the message gateway based on information from the subscription management module and the application management module.
Patent AU-2003272382-B2 (AU)
Title: Rotatable coin display
Inventor: HELZER JAMES A
IPC: A47F7/03
Filed: 2003-09-12
Granted: 2007-11-22
Abstract: A display for a collectible item, such as a coin, in which the collectible item may be rotated relative to the display. In one embodiment, the display comprises a bubble, which can be a semi-rigid transparent material, supported between at least two layers of support material, which can be a rigid material such as card-stock, which are adhered together. The bubble includes a capsule for encapsulating the collectible item, and a flange extending from an outer perimeter of the capsule. The capsule of the bubble is aligned within an opening in the support material so that the collectible item may be viewed. The flange contacts the support layers, and permits the bubble to be rotated within the display. The display also includes an apparatus for rotatably securing the flange between the support layers, which can be a high-gloss heat-resistant coating applied to the support layers over the areas in which the support layers contact the flange. The display can also include a third support layer between the first and second layers. The third layer has an opening that is slightly larger than the flange, so that the flange is located within the opening. The third layer preferably has a thickness that is substantially equal to the thickness of the flange to help minimize the formation of "humps" in the display caused by the added thickness of the flange. Methods for producing such a rotatable display are also disclosed.